رجوع
29
56
35
56
81
37
55
51
نطاق اليوم
KWD 98.41
KWD 100.95
نطاق 52 أسبوعًا
KWD 91.99
KWD 544.93
حجم التداول
1,126,902
متوسط 50 يوم / 200 يوم
KWD 122.45
/
KWD 258.44
الإغلاق السابق
KWD 98.05
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Technology (620 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 11.3 | 12.6 |
| P/B | 3.5 | 3.0 |
| ROE % | 38.1 | 8.9 |
| Net Margin % | 39.9 | 5.6 |
| Rev Growth 5Y % | 42.6 | 9.2 |
| D/E | 0.1 | 0.3 |
السعر المستهدف للمحللين
Hold
KWD 230.000
+130.6%
Low: KWD 100.000
High: KWD 330.000
مكرر الربحية المستقبلي
34.0
ربحية السهم المستقبلية
KWD 2.937
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
1.2 B
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2028 |
KWD 3.629
KWD 1.879 – KWD 5.530
|
1.6 B | 8 |
| FY2027 |
KWD 3.247
KWD 2.873 – KWD 3.525
|
1.4 B | 9 |
| FY2026 |
KWD 2.937
KWD 2.375 – KWD 3.280
|
1.2 B | 9 |
النقاط الرئيسية
Revenue grew 42.62% annually over 5 years — strong growth
Earnings grew 367.48% over the past year
ROE of 38.14% indicates high profitability
Net margin of 39.91% shows strong profitability
Debt/Equity of 0.07 — conservative balance sheet
Generating 369.73M in free cash flow
النمو
Revenue Growth (5Y)
42.62%
Revenue (1Y)38.71%
Earnings (1Y)367.48%
FCF Growth (3Y)62.55%
الجودة
Return on Equity
38.14%
ROIC7.06%
Net Margin39.91%
Op. Margin13.07%
الأمان
Debt / Equity
0.07
Current Ratio2.61
Interest Coverage0.00
التقييم
P/E Ratio
11.31
P/B Ratio3.48
EV/EBITDA27.59
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 38.71% | Revenue Growth (3Y) | 39.77% |
| Earnings Growth (1Y) | 367.48% | Earnings Growth (3Y) | 407.65% |
| Revenue Growth (5Y) | 42.62% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.04B | Net Income (TTM) | 414.07M |
| ROE | 38.14% | ROA | 20.78% |
| Gross Margin | 72.23% | Operating Margin | 13.07% |
| Net Margin | 39.91% | Free Cash Flow (TTM) | 369.73M |
| ROIC | 7.06% | FCF Growth (3Y) | 62.55% |
| Safety | |||
| Debt / Equity | 0.07 | Current Ratio | 2.61 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 11.31 | P/B Ratio | 3.48 |
| P/S Ratio | 4.51 | PEG Ratio | 0.06 |
| EV/EBITDA | 27.59 | Dividend Yield | 0.00% |
| Market Cap | 4.68B | Enterprise Value | 3.74B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.04B | 748.02M | 531.11M | 369.50M | 250.77M |
| Net Income | 414.07M | 88.57M | 16.07M | -59.57M | -60.14M |
| EPS (Diluted) | 8.57 | 1.88 | 0.35 | -1.51 | -1.57 |
| Gross Profit | 749.46M | 544.38M | 389.00M | 270.06M | 181.59M |
| Operating Income | 135.57M | 62.60M | -13.26M | -65.20M | -60.01M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.99B | 2.40B | 1.85B | 1.44B | 1.28B |
| Total Liabilities | 645.18M | 1.58B | 1.20B | 902.45M | 767.53M |
| Shareholders' Equity | 1.35B | 824.55M | 655.50M | 542.08M | 513.06M |
| Total Debt | 93.78M | 54.66M | 25.04M | 28.41M | 32.46M |
| Cash & Equivalents | 1.04B | 785.79M | 747.61M | 608.18M | 553.92M |
| Current Assets | 1.44B | 1.10B | 897.80M | 697.18M | 619.27M |
| Current Liabilities | 551.15M | 422.23M | 277.36M | 181.77M | 119.13M |
درجات الاستراتيجيات
This stock passed the criteria for 8 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#843 of 1024
Custom
Capital Light Compounder
#33 of 213
#275 of 658
Growth + Value
Growth at a Reasonable Price (Peter Lynch)
#125 of 326
#29 of 154
Custom
Full Throttle
#91 of 146
#21 of 195
Custom
Lower Risk
#41 of 136
النشاط الأخير
دخل
Cash Flow Compounder
Mar 24, 2026
دخل
Capital Light Compounder
Mar 24, 2026
دخل
Contrarian Investing (David Dreman)
Mar 24, 2026
دخل
Growth Investing (Philip Fisher)
Mar 24, 2026
دخل
Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026
دخل
Value Investing (Warren Buffett)
Mar 24, 2026
دخل
Full Throttle
Mar 24, 2026
دخل
Lower Risk
Mar 24, 2026